What factors may influence psychological well being at three months and one year post BRCA genetic result disclosure?

Breast

Volumn 21, Issue 6, 2012, Pages 755-760

  Bosch, Nina ^a,b   Junyent, Núria ^a   Gadea, Neus ^a   Brunet, Joan ^c   Ramon y Cajal, Teresa ^d   Torres, Asunción ^e   Graña, Begoña ^b   Velasco, Angela ^c   Darder, Esther ^c   Mensa, Irene ^a   Balmaña, Judith ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^c GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^d Hospital Sant Pau   (Spain)

^e HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

BRCA1 2 genetic testing; Hereditary breast and ovarian cancer; Oncology; Psychological impact

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE MUTATION; GENETIC SCREENING; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; TUMOR SUPPRESSOR GENE;

EID: 84869221882     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2012.02.004     Document Type: Article

References (30)

1. Metcalfe K.A., Birenbaum-Carmeli D., Lubinski J., Gronwald J., Lynch H., Moller P., et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 2008, 122:2017-2022.
2. Schwartz M.D., Peshkin B.N., Hughes C., Main D., Isaacs C., Lerman C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 2002, 20:514-520.
3. Reichelt J.G., Heimdal K., Moller P., Dahl A.A. BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Fam Cancer 2004, 3:21-28.
4. Meiser B., Butow P., Friedlander M., Barratt A., Schnieden V., Watson M., et al. Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer 2002, 38:2025-2031.
5. Watson M., Foster C., Eeles R., Eccles D., Ashley S., Davidson R., et al. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer 2004, 91:1787-1794.
6. Arver B., Haegermark A., Platten U., Lindblom A., Brandberg Y. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. Fam Cancer 2004, 3:109-116.
7. Hamilton R., Williams J.K., Skirton H., Bowers B.J. Living with genetic test results for hereditary breast and ovarian cancer. J Nurs Scholarsh 2009, 41:276-283.
8. Hughes Halbert C., Stopfer J.E., McDonald J., Weathers B., Collier A., Troxel A.B., et al. Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?. J Clin Oncol 2011, 29:4302-4306.
9. Julian-Reynier C., Mancini J., Mouret-Fourme E., Gauthier-Villars M., Bonadona V., Berthet P., et al. Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations. Eur J Hum Genet 2011, 19:500-506.
10. van Oostrom I., Meijers-Heijboer H., Lodder L.N., Duivenvoorden H.J., van Gool A.R., Seynaeve C., et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 2003, 21:3867-3874.
11. Lodder L., Frets P.G., Trijsburg R.W., Meijers-Heijboer E.J., Klijn J.G., Duivenvoorden H.J., et al. Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 2001, 98:15-24.
12. Coyne J.C., Kruus L., Racioppo M., Calzone K.A., Amstrong K. What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?. Am J Med Genet A 2003, 116A:222-228.
13. Cabrera E., Blanco I., Yague C., Zabalegui A. The impact of genetic counseling on knowledge and emotional responses in Spanish population with family history of breast cancer. Patient Educ Couns 2010, 78:382-388.
14. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
15. Quintana J.M., Padierna A., Esteban C., Arostegui I., Bilbao A., Ruiz I. Evaluation of the psychometric characteristics of the Spanish version of the hospital anxiety and depression scale. Acta Psychiatr Scand 2003, 107:216-221.
16. Ware J., Kosinski M., Keller S.D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
17. Spinhoven P., Ormel J., Sloekers P.P., Kempen G.I., Speckens A.E., Van Hermet A.M. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997, 27:363-370.
18. Herrero M.J., Blanch J., Peri J.M., De Pablo J., Pintor L., Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry 2003, 25:277-283.
19. Power T.E., Robinson J.W., Bridge P., Bernier F.P., Gilchrist D.M. Distress and psychosocial needs of a heterogeneous high risk familial cancer population. J Genet Couns 2011, 20:249-269.
20. Bish A., Sutton S., Jacobs C., Levene S., Ramirez A., Hodgson S. Changes in psychological distress after cancer genetic counseling: a comparison of affected and unaffected women. Br J Cancer 2002, 86:43-50.
21. Hamilton J.G., Lobel M., Moyer A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 2009, 28:510-518.
22. Lerman C., Narod S., Schulman K., Hughes C., Gomez-Caminero A., Bonney G., et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 1996, 275:1885-1892.
23. Croyle R.T., Smith K.R., Botkin J.R., Baty B., Nash J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 1997, 16:63-72.
24. Smith K.R., West J.A., Croyle R.T., Botkin J.R. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiol Biomarkers Prev 1999, 8:385-392.
25. Wagner T.M., Moslinger R., Langbauer G., Ahner R., Fleischmann E., Auterith A. Attitude towards prophylactic surgery and effects of genetic counseling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. Br J Cancer 2000, 82:1249-1253.
26. Claes E., Evers-Kiebooms G., Boogaerts A., Decruyenaere M., Denayer L., Legius E. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation. Genet Test 2004, 8:13-21.
27. Reichelt J.G., Moller P., Heimdal K., Dahl A.A. Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer. Fam Cancer 2008, 7:245-254.
28. Lodder L.N., Frets P.G., Trijsburg R.W., Meijers-Heijboer J.E., Klijn J.G., Seynaeve C., et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 2002, 73:97-112.
29. Broadstock M., Michie S., Gray J., Mackay J., Marteau T.M. The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer - a pilot study. Psychooncology 2000, 9:537-548.
30. Cella D., Hughes C., Peterman A., Chang C.H., Peshkin B.N., Schwartz M.D., et al. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 2002, 21:564-572.